Partner Headlines - PGNX

  1. Mid-Morning Market Update: Markets Rise; Ford Beats Q2 Estimates

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. Azedra Designated as Breakthrough Therapy for Iobenguane-Avid ...

    Benzinga
  4. Valeant Product Producer Progenics Announce European Approval ...

    Benzinga
  5. Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, ...

    GuruFocus
  6. Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall ...

    GuruFocus
  7. Morning Market Movers

    Benzinga
  8. Earnings Scheduled For November 7, 2014

    Benzinga
  9. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  10. Morning Market Losers

    Benzinga
  11. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  12. Earnings Scheduled For August 8, 2014

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  16. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  17. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  18. Progenics, Nektar Still Halted; FDA Advisory Committee Expected ...

    Benzinga
  19. Small Pharmaceuticals Rallying Following FDA Report

    Benzinga
  20. Mid-Afternoon Market Update; Hertz Down, QuikSilver Gain On CEO ...

    Benzinga
  21. Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; ...

    Benzinga
  22. Earnings Scheduled For May 9, 2014

    Benzinga
  23. Progenics Pharmaceuticals Announces Completion of Enrollment ...

    Benzinga
  24. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  25. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  26. Earnings Scheduled For March 13, 2014

    Benzinga
  27. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  28. Progenics Pharmaceuticals Announces the Appointment of Karen ...

    Benzinga
  29. Progenics Pharmaceuticals Relaunches Registrational Trial of ...

    Benzinga
  30. Earnings Scheduled For November 11, 2013

    Benzinga
  31. Salix Pharmaceuticals Thrives With Promising GI Drugs

    IBD
  32. Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX

    GuruFocus
  33. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  34. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  35. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  36. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  37. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  38. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  39. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  40. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  41. Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX

    GuruFocus
  42. Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys ...

    GuruFocus
  43. 5 Stocks That Dropped the Most Since Gurus Bought Them

    GuruFocus
  44. EZchip Semiconductor, Sagent Pharmaceuticals Among Stocks setting ...

    FoxBusiness
  45. Salix trounces Q2 estimates

    IBD
  46. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  47. Salix Pharmaceuticals Beats, Announces Licensing Deal

    IBD
  48. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily ...

    FoxBusiness
  49. Stocks Finish Little Changed Ahead of Central Bank Meetings with ...

    MarketIntelligenceCenter
  50. Salix, Progenics Stocks Fall On Drug Approval Delay

    IBD
  51. Stock Futures Mixed; Salix, Progenics Tumble

    IBD
  52. Benzinga's Top Pre-Market Losers

    Benzinga
  53. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga
  54. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    IBD
  55. Microcap Movers for Tuesday December 20, 2011

    Benzinga
  56. Stocks Bounce Back In Big Volume

    IBD
  57. Progenics Pharma Up 30% on Positive Phase 3 Results

    Benzinga
  58. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
  59. Morning Market Movers

    Benzinga
  60. Progenics Pharmaceuticals Lures Call Players in the Options Pits

    SchaeffersResearch
  61. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!